Assenagon Asset Management S.A. Has $20.59 Million Stock Position in Mettler-Toledo International, Inc. $MTD

Key Points

• Assenagon Asset Management S.A. reduced its holdings in Mettler-Toledo International, Inc. by 68.4%, resulting in a position valued at approximately $20.59 million after selling 37,977 shares.
• Insider sells included significant dispositions by company executives, with insider Gerry Keller selling 165 shares for $215,925.60, representing a 63.71% decrease in their ownership.
• Mettler-Toledo's recent earnings report indicated a profit of $10.09 per share, exceeding estimates and showing a year-over-year revenue increase of 3.9% to $983.22 million.

Assenagon Asset Management S.A. lowered its holdings in Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 68.4% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 17,527 shares of the medical instruments supplier's stock after selling 37,977 shares during the quarter. Assenagon Asset Management S.A. owned 0.08% of Mettler-Toledo International worth $20,589,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of MTD. Greenleaf Trust grew its position in Mettler-Toledo International by 1.2% in the 1st quarter. Greenleaf Trust now owns 872 shares of the medical instruments supplier's stock worth $1,030,000 after purchasing an additional 10 shares during the last quarter. Brooklyn Investment Group grew its position in Mettler-Toledo International by 12.8% during the first quarter. Brooklyn Investment Group now owns 88 shares of the medical instruments supplier's stock worth $104,000 after buying an additional 10 shares in the last quarter. Sequoia Financial Advisors LLC grew its position in Mettler-Toledo International by 1.8% during the first quarter. Sequoia Financial Advisors LLC now owns 627 shares of the medical instruments supplier's stock worth $740,000 after buying an additional 11 shares in the last quarter. Albion Financial Group UT grew its position in Mettler-Toledo International by 1.5% during the first quarter. Albion Financial Group UT now owns 754 shares of the medical instruments supplier's stock worth $890,000 after buying an additional 11 shares in the last quarter. Finally, TD Private Client Wealth LLC grew its holdings in shares of Mettler-Toledo International by 5.4% during the 1st quarter. TD Private Client Wealth LLC now owns 214 shares of the medical instruments supplier's stock worth $253,000 after purchasing an additional 11 shares in the last quarter. Institutional investors and hedge funds own 95.07% of the company's stock.

Insiders Place Their Bets

In other Mettler-Toledo International news, insider Gerry Keller sold 165 shares of the firm's stock in a transaction that occurred on Thursday, August 14th. The shares were sold at an average price of $1,308.64, for a total transaction of $215,925.60. Following the sale, the insider directly owned 94 shares in the company, valued at approximately $123,012.16. This trade represents a 63.71% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Thomas P. Salice sold 1,062 shares of the firm's stock in a transaction that occurred on Wednesday, August 13th. The stock was sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the sale, the director owned 283 shares in the company, valued at $368,154.70. This trade represents a 78.96% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 1,827 shares of company stock worth $2,371,208. Company insiders own 0.77% of the company's stock.

Mettler-Toledo International Stock Down 0.6%

MTD stock opened at $1,257.79 on Tuesday. The business's fifty day moving average is $1,266.00 and its 200-day moving average is $1,184.96. The company has a market cap of $25.91 billion, a P/E ratio of 31.85, a price-to-earnings-growth ratio of 3.79 and a beta of 1.37. Mettler-Toledo International, Inc. has a twelve month low of $946.69 and a twelve month high of $1,521.01.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last released its earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share for the quarter, beating the consensus estimate of $9.58 by $0.51. The firm had revenue of $983.22 million for the quarter, compared to analyst estimates of $957.41 million. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The company's quarterly revenue was up 3.9% on a year-over-year basis. During the same quarter in the prior year, the firm posted $9.65 earnings per share. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. Research analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several brokerages have recently weighed in on MTD. Robert W. Baird lifted their price objective on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a "neutral" rating in a report on Monday, August 4th. Bank of America lifted their target price on shares of Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the company a "neutral" rating in a research report on Monday. Citigroup boosted their price target on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a "buy" rating in a research note on Thursday, August 21st. Evercore ISI reduced their target price on shares of Mettler-Toledo International from $1,280.00 to $1,275.00 and set an "outperform" rating on the stock in a research note on Monday, August 4th. Finally, Barclays assumed coverage on shares of Mettler-Toledo International in a research note on Tuesday, June 24th. They issued an "overweight" rating and a $1,325.00 target price on the stock. Five research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $1,325.56.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International, Inc. (NYSE:MTD - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.